HUYA Bioscience International Announces Strategic Partnership With The Tianjin Institute Of Pharmaceutical Research

HUYA Bioscience International Announces Strategic Partnership With The Tianjin Institute Of Pharmaceutical Research

San Diego, CA, USA – January 18, 2012 — HUYA Bioscience International today announced a strategic partnership agreement with the Tianjin Institute of Pharmaceutical Research (TIPR). HUYA is a leader in globalizing China’s biopharmaceutical innovations and TIPR is one of the leading pharmaceutical research institutes in China. The collaborative agreement will combine both parties‘ strengths in promoting the advancement of China’s drug innovations.